Drug Profile
Research programme: fluoroquinolone antibacterials - Wakunaga
Alternative Names: Wfq-101; WFQ-228; WQ-2932; WQ-3335Latest Information Update: 27 Dec 2022
Price :
$50
*
At a glance
- Originator Wakunaga Pharmaceutical
- Class Fluoroquinolones; Small molecules
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pneumococcal infections
- Discontinued Bacterial infections
Most Recent Events
- 27 Dec 2022 Discontinued - Preclinical for Bacterial infections in Japan (PO)
- 28 Jul 2020 No recent reports of development identified for preclinical development in Bacterial-infections in Japan (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Pneumococcal-infections in Japan (PO)